Literature DB >> 1879482

Rubella vaccines: past, present and future.

J M Best1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879482      PMCID: PMC2272034          DOI: 10.1017/s0950268800048640

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


× No keyword cloud information.
  76 in total

1.  Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

Authors:  P L Ogra; D Kerr-Grant; G Umana; J Dzierba; D Weintraub
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

2.  Recurrent joint symptoms in children vaccinated with HPV-77DK12 rubella vaccine.

Authors:  S L Spruance; L E Klock; A Bailey; J R Ward; C B Smith
Journal:  J Pediatr       Date:  1972-03       Impact factor: 4.406

3.  Rubella vaccination and thrombocytopenia.

Authors:  J M Forrest; M C Honeyman; V A Lovric
Journal:  Aust N Z J Med       Date:  1974-08

4.  Polyneuropathy following rubella immunization. A follow-up study and review of the problem.

Authors:  W Schaffner; W F Fleet; A W Kilroy; L B Lefkowitz; K L Herrmann; J Thompson; D T Karzon
Journal:  Am J Dis Child       Date:  1974-05

5.  Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.

Authors:  S A Plotkin; J D Farquhar; P L Ogra
Journal:  JAMA       Date:  1973-08-06       Impact factor: 56.272

6.  Influence of age on clinical response to HPV-77 duck rubella vaccine.

Authors:  R E Weibel; J Stokes; E B Buynak; M R Hilleman
Journal:  JAMA       Date:  1972-11-13       Impact factor: 56.272

7.  Attenuated rubella virus. I. Development and laboratory characterization.

Authors:  P D Parkman; H M Meyer; R L Kirschstein; H E Hopps
Journal:  N Engl J Med       Date:  1966-09-15       Impact factor: 91.245

8.  Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals.

Authors:  C Huygelen; J Peetermans
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis.

Authors:  C A Mims; A Stokes; R Grahame
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

10.  Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.

Authors:  J E Cradock-Watson; H Macdonald; M K Ridehalgh; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1974-08
View more
  11 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana.

Authors:  J E Lawn; S Reef; B Baffoe-Bonnie; S Adadevoh; E O Caul; G E Griffin
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Sequence variation in 5' termini of rubella virus genomes: changes affecting structure of the 5' proximal stem-loop.

Authors:  P Johnstone; J E Whitby; T Bosma; J M Best; P G Sanders
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 4.  Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  1999-12-04

Review 5.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

6.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  PCR for detection of rubella virus RNA in clinical samples.

Authors:  T J Bosma; K M Corbett; S O'Shea; J E Banatvala; J M Best
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.

Authors:  Alexander L Pukhalsky; Galina V Shmarina; Maria S Bliacher; Irina M Fedorova; Anna P Toptygina; Julia J Fisenko; Vladimir A Alioshkin
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

Review 9.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

10.  Congenital rubella syndrome: pattern and presentation in a southern Nigerian tertiary hospital.

Authors:  Innocent Ocheyana George; Angela Ine Frank-Briggs; Raphael Sonny Oruamabo
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 9.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.